Forte Biosciences (FBRX) Property, Plant & Equipment (Net) (2016 - 2026)

Forte Biosciences (FBRX) Property, Plant & Equipment (Net) (2016 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - 642,333.36
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - 5.32 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 1.64 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 1.61 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 5.27 Bn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 1.96 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn - 31.48 Mn
10 Forte Biosciences 1.37 Bn 1.31 Bn - 110,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 110,000.00
Mar 31, 2026 110,000.00
Dec 31, 2025 129,000.00
Dec 31, 2025 129,000.00
Sep 30, 2025 148,000.00
Sep 30, 2025 148,000.00
Jun 30, 2025 110,000.00
Jun 30, 2025 110,000.00
Mar 31, 2025 125,000.00
Mar 31, 2025 125,000.00
Dec 31, 2024 77,000.00
Dec 31, 2024 77,000.00
Sep 30, 2024 86,000.00
Sep 30, 2024 86,000.00
Jun 30, 2024 96,000.00
Jun 30, 2024 96,000.00
Mar 31, 2024 106,000.00
Mar 31, 2024 106,000.00
Dec 31, 2023 109,000.00
Dec 31, 2023 109,000.00